Company can not raise money for their own product developments at current levels.
Share price needs to rise in any case.
How to facilitate this?
Peros has done this several times and my guess is that he has enough connections to meaningfully engage money backing the story.
Otherwise I very much doubt he would have taken the job.
On the other hand, company must bank on his expertise as he is not cheap.
Management used the P&G partnership to pique his interest, one would think.
That gave him enough to play with to attract interest from money sources, IMO.
The investment he would be seeking can be returned multiple times if his track record applies to this company and similar returns can be achieved over time.
Company landed something out of the real world here, hence my interest again.
Price target for next 2 weeks is 2.2 cents with a retrace to 1.8 cent.
From there I would expect some news supporting a further push towards 3.5 by Sept.
Whether Peros can attract investment or the money comes in form of a CR, price needs to be higher to generate enough funding for our own products.
Trading action supports a push towards the low 2's soon, IMO.
- Forums
- ASX - By Stock
- WFL
- The July 4C
The July 4C, page-27
-
- There are more pages in this discussion • 126 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online